- Home
- UNCY vs IROQ Comparison
UNCY vs IROQ Comparison
Compare UNCY & IROQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- IROQ
- Stock Information
- Founded
- UNCY 2016
- IROQ 1883
- Country
- UNCY United States
- IROQ United States
- Employees
- UNCY N/A
- IROQ N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- IROQ Savings Institutions
- Sector
- UNCY Health Care
- IROQ Finance
- Exchange
- UNCY Nasdaq
- IROQ Nasdaq
- Market Cap
- UNCY 91.0M
- IROQ 75.0M
- IPO Year
- UNCY 2021
- IROQ 2011
- Fundamental
- Price
- UNCY $4.55
- IROQ $24.28
- Analyst Decision
- UNCY Strong Buy
- IROQ
- Analyst Count
- UNCY 4
- IROQ 0
- Target Price
- UNCY $63.75
- IROQ N/A
- AVG Volume (30 Days)
- UNCY 1.5M
- IROQ 1.3K
- Earning Date
- UNCY 08-13-2025
- IROQ 08-28-2025
- Dividend Yield
- UNCY N/A
- IROQ 1.65%
- EPS Growth
- UNCY N/A
- IROQ 69.23
- EPS
- UNCY N/A
- IROQ 1.05
- Revenue
- UNCY N/A
- IROQ $25,099,000.00
- Revenue This Year
- UNCY N/A
- IROQ N/A
- Revenue Next Year
- UNCY $1,458.53
- IROQ N/A
- P/E Ratio
- UNCY N/A
- IROQ $23.18
- Revenue Growth
- UNCY N/A
- IROQ 12.02
- 52 Week Low
- UNCY $2.02
- IROQ $16.34
- 52 Week High
- UNCY $11.00
- IROQ $25.76
- Technical
- Relative Strength Index (RSI)
- UNCY 39.53
- IROQ 48.51
- Support Level
- UNCY $4.76
- IROQ $24.35
- Resistance Level
- UNCY $7.15
- IROQ $24.98
- Average True Range (ATR)
- UNCY 0.97
- IROQ 0.28
- MACD
- UNCY -0.28
- IROQ -0.04
- Stochastic Oscillator
- UNCY 7.37
- IROQ 59.78
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About IROQ IF Bancorp Inc.
IF Bancorp Inc is a holding company. It is mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company with the association take deposits from the general public and invest those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, others and also a variety of deposit accounts and alternative delivery channels.